baber/WOPTO huggingface dataset:
Patent JP-4067140-B2 (JP)
IPC: C08L9/00
Filed: 1995-07-14
Granted: 2008-03-26
Abstract: Diene polymers functionalised with an epoxidised alkoxysilane are prepd. by catalysed prepn. of a living diene polymer and addn. to the living polymer of an agent of formula (Y)m-R<1>-Si(OR<2>)3-n-R<3>n (I). In (I), Y = a gp. of formula (i) or (ii); R<1> = 1-10C alkyl, cycloalkyl or aryl; R<2> = 1-12C alkyl, aryl, cycloalkyl, alkaryl or aralkyl; R<3> = 1-12C alkyl, aryl or alkaryl; R<4> = 1-6C hydrocarbon gp., opt. with O atom(s) in the chain; n = 0 or 1; m = 1 or 2; p, q = 0-4; and p+q = 2-5. The amt. of (I) used is such that the molar ratio (RM) of (I):active sites in the initiator is at least 1. Redn. of the hysteresis of dienic polymer vulcanisates by modification with (I), and addn. of SiO2 and the usual components of S-vulcanisable compsns., is also claimed. <IMAGE>
Patent JP-2603260-B2 (JP)
IPC: B60T8/58
Filed: 1987-07-24
Granted: 1997-04-23
Abstract: PURPOSE:To satisfy both stability in lateral direction and an accelerating property at the time of steering starting by lowering the target value of a slip control by means of the application of braking force without varying the target value of a slip control by means of the lowering of a generating torque, at the time of the steering starting. CONSTITUTION:A control means for a power source and a control means for brakes receive the output of a slip detecting means and carry out slip control so as to make the slip of driving wheels each of a first target value and a second target value by controlling a braking force adjusting means. A second target value varying means receives the outputs of a low vehicle speed detecting means and a steering angle detecting means and, at the time of low vehicle speed, varies only the second target value in a reducing direction without varying the first target value in accordance with the steering angle of a handle. Thereby, during cornering at the time of steering starting, stability in lateral direction can be ensured by lowering the second target value for braking. At the same time, an accelerating property can be ensured since the first target value for power source is maintained as it is.
Patent JP-S6257061-B2 (JP)
IPC: H01J35/10
Filed: 1980-12-26
Abstract: Improved rotary targets for X-ray tubes are provided which include a substrate body (16) of a high strength molybdenum alloy, an intermdeiate ductile layer (22) of pure molybdenum or a ductile molybdenum alloy affixed to the top surface thereof and an electron receiving layer (24) made of a tungsten-based alloy affixed to at least a portion of the intermediate layer.
Patent JP-H0349612-B2 (JP)
IPC: F26B11/06
Filed: 1989-08-07
Abstract: In a drum which is rotatable about a horizontal axis of rotation, inlet and outlet lines for a gas, for drying a material contained in the drum, are connected to an immersion body. The immersion body has inlet and outlet openings for the gas and is disposed within the drum to be immersed in the material. The immersion body contains a tunnel through which the material can flow and has arranged in its interior at least some of the inlet and outlet openings for the gas.
Patent JP-2678499-B2 (JP)
IPC: C07D233/72
Filed: 1989-08-09
Granted: 1997-11-17
Abstract: Pharmaceutical compositions are disclosed for use in preventing or treating renal failure in mammals which comprise as active ingredient at least one hydantoin derivative of the following formula (I) or a pharmaceutically acceptable salt or complex thereof. <CHEM> n
Patent JP-3780124-B2 (JP)
IPC: B23K35/14
Filed: 1999-07-22
Granted: 2006-05-31
Abstract: A mono-component brazing powder (5) is used for a brazing-diffusion process of superalloy parts (1,2) and comprises preparing superalloy powder of the same composition as the parts and 0.1-40 wt.% of a powder of at least one fluxing element (7) chosen in the boron and silicon group. Brazing-diffusion process of superalloy A parts comprises: (a) preparing superalloy A powder of the same composition as the parts and 0.1-40 wt.% of a powder of at least one fluxing element chosen in the boron and silicon group; (b) mixing the powders, and adding beads in a container; the beads and the container are made of a superalloy A, closing the container and maintaining under controlled atmosphere; (c) placing the container in a crusher and moving the container for 30 s- 500 h in order to incorporate the fluxing element in the surface of the superalloy powder grains; (d) cleaning in a chemical bath the parts surface to be brazed; (e) heat treating by thermochemical treatment the parts; (f) depositing on the parts surface the monocomponent powder obtained in the step (c); (g) performing a thermal cycle of oven brazing comprising ramping the temperature in stages up to a brazing temperature of 1050-1400 degrees C determined according to the superalloy and holding for 15-30 minutes; and (h) diffusion by thermal treatment in an oven under controlled atmosphere for 4-16 hours.
Patent JP-2843985-B2 (JP)
IPC: C08F226/06
Filed: 1988-09-02
Granted: 1999-01-06
Abstract: The invention relates to a polymer suitable as a dispersant, built up from     A) 0-80 mol % of one or more monomers having the formula <CHEM> in which R1, R2, R3 and R4 may be the same or different and represent H or alkyl,   B) 0-70 mol % of one or more monomers having the formula <CHEM> in which R5, R6 and R7 may be the same or different and represent H or alkyl and R8 is alkyl or substituted alkyl, and the alkyl group R8 may also be interrupted by - O - groups, C) 5-50 mol % of one or more monomers containing a heterocyclic group having at least one basic ring nitrogen atom, or to which such a heterocyclic group is attached following polymerization, D) 0-10 mol % of one or more monomers containing one or more groups reactive to cross-linking or coupling, and E) 0-20 mol % of one or more monomers not falling within the groups A-D, the amount of monomers from group A together with monomers containing an acrylate group being at least 20 mol %, as well as organic salts thereof, and also to the use thereof.
Patent JP-4401485-B2 (JP)
IPC: B01J27/045
Filed: 1999-08-04
Granted: 2010-01-20
Abstract: The present invention relates to a catalyst consisting of a metal of the VIII group supported on acid activated carbon functionalized with sulfonic groups, a process for the synthesis of hydrogen peroxide from hydrogen and oxygen which uses said catalyst and the use of the hydrogen peroxide solution in oxidation processes catalyzed by titanium-silicalite. <IMAGE>
Patent JP-3655134-B2 (JP)
IPC: G01G23/00
Filed: 1999-08-20
Granted: 2005-06-02
Abstract: The overload protection has a load sensor (27) with a first part (56), to transmit the force to the measurement device, which is connected to a second part (57), to transfer the force to a measurement transducer, by two parallel connecting rods (58,59) that are perpendicular to the direction of force transmission, to form a parallelogram. The connecting rods have a pretensioned elastic element (78) tensioned between engagement areas formed with the first and second parts. The two parts and the two connecting rods are formed from one-part contiguous material areas of a material block (1), in which they are bordered by material free areas (55) formed in the block.
Patent JP-H0725905-B2 (JP)
IPC: G03F1/62
Filed: 1990-09-06
Abstract: A pellicle comprising a thin, durable film of substantially uniform thickness which absorbs less than 10% light at wavelengths between 190 and 820 nanometers, tautly adhered to one edge of an enclosed support frame, said thin film comprising amorphous fluoropolymers having a refractive index between 1.24 and 1.41. Pellicles of this type are dust defocusing covers for photomasks and reticles used to project patterns onto light sensitive substrates such as photoresist-coated semiconductor wafers which are used in the manufacture of integrated circuits.
Patent JP-H0612863-B2 (JP)
IPC: H03H17/06
Filed: 1987-09-22
Abstract: A sampled data treble control system, requiring a single multiplier element (22), includes the cascade connection of a first adder (20), the multiplier (22), and a second adder (24) coupled between the system input and output terminals. A subtracter (32) develops the differences between the system input and output signals and applies them to an IIR filter (26,28,30). The filtered differences are scaled and coupled to the first (20) and second adders (24). The system transfer function H(Z) is given by      H(Z) = [1+(Z-1)/(1+1/A)K]/[1+(Z-1)/(1+A)K] where A is a treble control variable applied to the multiplier (22), K is a scaling constant and Z is the conventional Z-transform variable.
Patent JP-H0556905-B2 (JP)
Inventor: PIITAA RONARUDO HOORU
IPC: A61B8/06
Filed: 1988-10-08
Abstract: A device for positioning/retaining a transducer relative to a body characterised in that it comprises a supporting member for placement on the body, connected thereto one end of a flexible and elongate arm, which has a mount for the transducer at or near the remote end thereof, and means for locking the arm in a fixed position relative to the body is disclosed. Also disclosed are an apparatus for monitoring aortic blood velocity and derived parameters by Dappler ultrasound and, optionally, ECG comprising such a device and that use of such an apparatus.
Patent JP-H07116027-B2 (JP)
IPC: A61K9/06
Filed: 1986-10-28
Abstract: Pain and or inflammation is treated by transdermal administration of 2-amino-3-benzoyl-benzeneacetic acids, salts and esters having the formula 
<CHEM>
 wherein R<1> is hydrogen, loweralkyl or a pharmaceutically acceptable cation; R<2> is hydrogen, halogen, loweralkyl or loweralkoxy; R<3>, R<4> and R<5> are hydrogen or loweralkyl; X is hydrogen, halogen, loweralkyl, hydroxy, loweralkoxy, nitro, trifluoromethyl or loweralkylthio; Y is hydrogen, loweralkyl, loweralkoxy, nitro or trifluoromethyl and hydrates and alcoholates thereof.
Patent JP-H088927-B2 (JP)
IPC: A61F9/02
Filed: 1987-10-19
Abstract: In order to obtain goggles or visors which have uniformly good mechanical and optical properties, in particular high resistance to deformation and scratching, as well as non-fogging and transparency, and which can be manufactured industrially in a cost-effective manner, it is proposed that the panel (3) consist of two transparent plastic panels (4, 5) connected by means of an adhesive, the inner panel (5) being a cellulose derivative panel whose surface is glued to the second panel (4) by means of a transparent adhesive based on silicone rubber, with the formation of an adhesive layer (6). <IMAGE>
Patent JP-3910654-B2 (JP)
IPC: C07C281/06
Filed: 1995-09-21
Granted: 2007-04-25
Abstract: Prepn. of a 5-hydrocarbyloxy-2,4-dihydro-3H-1,2,4-triazol-3-one of formula (I) comprises: (i) reacting an imino(thio)carbonate diester of formula (II) with an alkoxyethyl carbazate of formula (III), opt. in presence of a reaction auxiliary and/or a diluent, at -20 to +150 (pref. 0-120, esp. 10-100) degrees C; and (ii) subjecting the obtd. semicarbazide deriv. of formula (IV) (or its tautomer), opt. after isolation, to cyclising condensation at 0-200 (pref. 50-180) degrees C, opt. in a diluent and/or under reduced pressure. R<1>, R<2> = alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl; R<1> can also be H; Q = O or S; R<3> = alkyl, aryl or aralkyl (all opt. substd.); R<4> = opt. substd. alkyl. Intermediates (IV), including their tautomers, are new cpds.
Patent JP-2634415-B2 (JP)
IPC: A61K8/00
Filed: 1987-10-27
Granted: 1997-07-23
Abstract: This invention relates to improved personal skin care products which contain dimethyl diallyl ammonium chloride/acrylic acid-type polymers. These polymers provide exceptional f to skin when personal skin care products containing them, such as hand and face lotions, soaps or creams, suntan lotions, bubble baths, shaving creams, antiperspirants, and deodorants, are used.
Patent JP-2959598-B2 (JP)
IPC: A61P37/08
Filed: 1991-10-09
Granted: 1999-10-06
Abstract: Stable crystals of an acid addition salt of an optically active thienotriazolodiazepine compound or its hydrate of the formula <CHEM> wherein R<1> is hydrogen, R<2> is 2-phenylethyl substituted by alkyl having 1 to 5 carbon atoms, 2-morpholinocarbonylethyl or alkyl having 6 to 12 carbon atoms, or R<1> and R<2> may combinedly form a saturated 5-membered ring having one substituent selected from the group consisting of morpholinomethyl, morpholinocarbonyl and N,N-dipropylcarbamoyl, R<3> is halogen, alkyl having 1 to 5 carbon atoms or alkoxy having 1 to 5 carbon atoms, R<4> is trifluoromethyl or alkyl having 1 to 5 carbon atoms, R<5> is hydrogen or methyl, m is 1-2, and n is 0-2. The present invention provides optically active thienotriazolodiazepine compounds having strong PAF-antagonistic activity as markedly stable crystals which are excellent in crystalline property, permit purification by recrystallization, and have high chemical purity and optical purity, thereby rendering industrial large-scale synthesis attainable. In addition, crystallization thereof facilitates medicinal standardization and pharmaceutical formulation.
Patent JP-3322971-B2 (JP)
IPC: C07D209/08
Filed: 1993-12-17
Granted: 2002-09-09
Abstract: The invention relates to indoline compounds of formula (I): <IMAGE>  in which:   R1 and R2 denote hydrogen, alkyl, monohydroxyalkyl, polyhydroxyalkyl, nitro, hydroxyl, alkoxy or NHR where R can be hydrogen, alkyl, monohydroxyalkyl or polyhydroxyalkyl;   X denotes oxygen or sulphur;   R3 represents -OR4 or NR5R6 where     R4 denotes alkyl, alkenyl, benzyl, alkoxyalkyl or haloalkyl;   R5 and R6 denote alkyl;   R1 and R2 do not simultaneously denote hydrogen or nitro and when R1 denotes alkyl, alkoxy or mono- or polyhydroxyalkyl, R2 denotes NHR or hydroxyl, and to their use in dyeing keratinous fibres.a
Patent JP-3135122-B2 (JP)
IPC: G01N33/74
Filed: 1990-10-25
Granted: 2001-02-13
Abstract: A human blood peptide, hPTH (1-37), the structure of which has been elucidated, can be used as a drug for diagnostic, medical and industrial purposes. The isolation of an hPTH (38-84) fragment demonstrates the existence of the hPTH (1-37). Removal of amino-terminal amino acids on the hPTH (1-37) reduces its biological activity. The hPTH (1-37) which circulates in the blood is identical to the synthetic reference substance hPTH (1-37), but not fragments such as hPTH (1-33), hPTH (1-34) or hPTH (1-38). The existence of the hPTH (1-37) molecular form was proved by mass spectroscopy (plasma desorption method). A different biological activity and differences in the three-dimensional peptide structure between the hPTH (1-37) fragment and other hPTH fragments prove that this hPTH fragment is the preferred natural peptide of the parathormone family, which should be used for treating diseases of the parathyroids, the circulatory and respiratory systems, the male genital organ and the kidneys.
Patent JP-H0627329-B2 (JP)
IPC: C23C16/455
Filed: 1985-02-12
Abstract: Described is a method for depositing from the vapor phase a chemical species into the form of a thin solid film material which overlays a substrate material. The deposition process consists of three steps: (1) synthesis of depositing species, (2) transport of said species from site of synthesis to a prepared substrate material, and (3) condensation and subsequent film growth. The transport step is achieved by admixing small concentrations of the depositing species into the flow of a high speed jet of an inert carrier gas. This jet impinges on the substrate's surface and thereby convects the depositing species to this surface where condensation occurs. Since the gas mixture is at fairly high pressure, the deposition is achieved in a simple flow apparatus rather than in the high vacuum systems required of other methods. Also this transport technique allows the chemical and/or physical phenomena utilized in the depositing species synthesis step to be isolated from the actual condensation reaction. Consequently, the conditions governing each of these reactions can be varied independently to optimize both steps. Such flexibility permits the synthesis and deposition of a wide variety of chemical species, hence many thin film materials are susceptible to formation by this method.
Patent JP-H0223428-B2 (JP)
IPC: B31B50/20
Filed: 1982-04-02
Abstract: Easily opened and reclosable bags for packaging snacks or the like. Each bag (20) includes an unsealed area (33) that facilitates separation of a seal (24) without tearing the bag. Another integral portion (26) of the bag provides reclosure. Sealing jaws (70A and 70B) that are adapted for forming and filling apparatus form the bag seal sections (26 and 32) comprising seal (24), including the reclosure element (26) and unsealed area (33).
Patent JP-2739378-B2 (JP)
IPC: C12Q1/68
Filed: 1991-11-08
Granted: 1998-04-15
Abstract: The present invention relates to a method of forming a three-stranded DNA molecule wherein each strand of the three-stranded DNA molecule is hybridized (that is, non-covalently bound) to at least one other strand of the three-stranded DNA molecule. The method comprises: contacting a recombination protein with a double-stranded DNA molecule and with a single-stranded DNA molecule sufficiently complementary to one strand of the double-stranded DNA molecule to hybridize therewith, which contacting is effected under conditions such that the single-stranded DNA molecule hybridizes to the double-stranded molecule so that the three stranded DNA molecule is formed.
Patent JP-3464484-B2 (JP)
IPC: E02D29/02
Filed: 1994-06-24
Granted: 2003-11-10
Abstract: An earth structure comprises a plurality of elongate stabilising elements (3) in an earth mass behind a facing made up of facing panels (1), and a plurality of connectors (2) behind the facing and connecting it to the stabilising elements (3). Each connector (2) has a rear attachment portion (8) attached to a respective stabilising element (3) and at least two spaced apart front attachment portions (6) attached to the facing. The earth mass comprises a first region (20) of soil suitable for plant growth, in which first region (20) the connectors (2) are located, and a second region (21) of structural backfill, in which second region (21) the stabilising elements (3) are located. <IMAGE>
Patent JP-3121346-B2 (JP)
IPC: C25D7/00
Filed: 1992-07-22
Granted: 2000-12-25
Abstract: PCT No. PCT/DE92/00605 Sec. 371 Date Apr. 6, 1994 Sec. 102(e) Date Apr. 6, 1994 PCT Filed Jul. 22, 1992 PCT Pub. No. WO93/03204 PCT Pub. Date Feb. 18, 1993.An aqueous acid bath for the galvanic deposition of bright, ductile and smooth copper coats which is suitable for decorative purposes as well as for strengthening the conductors of printed circuits. The bath is characterized by a content of polyalkylene glycol ether. When combined with thio compounds containing water-soluble groups, these additions produce an electrolyte with excellent stability. Polymeric phenazonium compounds, polymeric nitrogen compounds and/or thio compounds containing nitrogen may also be successfully combined, in addition, depending on the desired properties.
Patent JP-3171255-B2 (JP)
IPC: C05G5/14
Filed: 1991-03-27
Granted: 2001-05-28
Abstract: A carrierless granular slow release fertilizer composition is prepared by spraying a urea-formaldehyde resin composition having a U/F molar ratio ranging from 2.4 to 13.3 onto finely divided solid particulate raw materials and cooling the resulting sprayed product to solidify the resin composition providing a matrix within which the solid particulate raw materials are bound. The fertilizer composition is characterized by having desired physical and chemical properties in regard to chain length of nitrogen polymers in the product, nitrogen release patterns, hardness and dust free nature of the product and the dispersibility characteristics of the product. The product has an abrasion index of about 0.800-1.000.
Patent JP-3411038-B2 (JP)
IPC: C07D413/12
Filed: 1994-09-12
Granted: 2003-05-26
Abstract: The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
Patent JP-2975428-B2 (JP)
IPC: C11D7/42
Filed: 1990-06-25
Granted: 1999-11-10
Abstract: The shelf life of a liquid enzymatic cleaner is prolonged if the cleaner consists of 1,000 to 90,000 U/ml of protease, 5 to 500 BGU/ml of glucanase, 1 to 10 wt.% of anionic and/or nonionic tensides, 20 to 60 wt.% of a hydrophilic organic solvent, 1 or more acids of boron and/or their soluble salts and, if desired, buffers or complexing agents.
Patent JP-3859695-B2 (JP)
IPC: A61K38/00
Filed: 1990-08-02
Granted: 2006-12-20
Abstract: Disclosed are methods and compositions for identifying malignant tumors that overexpress the c-erbB-2 oncogene. Assays useful for diagnosis and prognosis of neoplastic disease are provided which detect the external domain of c-erbB-2, the glycoprotein gp75 and quantitate the level of gp75 in the biological fluids of mammals carrying a tumor burden.  Further disclosed are recombinant, synthetically and otherwise biologically produced novel proteins and polypeptides which are encoded by the external domain DNA sequence of the c-erbB-2 oncogene (the gp75 gene) or fragments thereof. Such gp75 proteins and polypeptides are useful as vaccines, therapeutically in the treatment of cancer either alone or in combination with chemotherapeutic agents.  Also disclosed are antibodies to such gp75 proteins and polypeptides which are useful diagnostically and therapeutically. Still further disclosed are test kits embodying the assays of this invention.
Patent JP-3691055-B2 (JP)
IPC: C07K14/32
Filed: 1994-02-10
Granted: 2005-08-31
Abstract: PCT No. PCT/EP94/00427 Sec. 371 Date Nov. 1, 1995 Sec. 102(e) Date Nov. 1, 1995 PCT Filed Feb. 10, 1994 PCT Pub. No. WO94/18330 PCT Pub. Date Aug. 18, 1994A method is provided for immobilizing a binding protein capable of binding to a specific compound, using recombinant DNA techniques for producing said binding protein or a functional part thereof. The binding protein is immobilized by producing it as part of a chimeric protein also comprising an anchoring part derivable from the C-terminal part of an anchoring protein, thereby ensuring that the binding protein is localized in or at the exterior of the cell wall of the host cell. Suitable anchoring proteins are yeast  alpha -agglutinin, FLO1 (a protein associated with the flocculation phenotype in S. cerevisiae), the Major Cell Wall Protein of lower eukaryotes, and a proteinase of lactic acid bacteria. For secretion the chimeric protein can comprises a signal peptide including those of  alpha -mating factor of yeast,  alpha -agglutinin of yeast, invertase of Saccharomyces, inulinase of Kluyveromyces,  alpha -amylase of Bacillus, and proteinase of lactic acid bacteria. Also provided are recombinant polynucleotides encoding such chimeric protein, vectors comprising such polynucleotide, transformed microorganisms having such chimeric protein immobilized on their cell will, and a process for carrying out an isolation process by using such transformed host, wherein a medium containing said specific compound is contacted with such host cell to form a complex, separating said complex from the medium and, optionally, releasing said specific compound from said binding protein.